we can not at present share the view that the primary endobronchial administration of epinephrine is to be regarded as the treatment of first choice in every case of asystolic cardiac arrest ( j. schuttler et al. , anasth . intensiwther . notfallmed. , 22 ( 1987 ) 63 ) , as in most cases peripheral venous access can readily be established , thus avoiding the possible disadvantages of endobronchial administration ( prolonged tachycardia , hypertension , arrhythmia from the depot effect , and also additional impairment of the pulmonary gas exchange ) .
C0014563
epinephrine
C0018790
cardiac arrest